This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Angst J (1981) Ungelöste Probleme bei der Indikationsstellung zur Lit hiumprophylaxe affektiver and schizoaffektiver Erkrankungen. Bibl Psychiatr 161: 34–44
Angst J, Bech P, Bruinvels J, Engel RR, Ferner U, Guelfi JD, Lingjaerde O, Müller-Oerlinghausen B, Paes de Sousa M, Paykel E, Rimon R, Rzewuska M, Saletu B, Spiegel R, Stassen HH, Stoll KD, Wiesel FA, Woggon B, Zvolsky P (1994) Report on the fifth consensus conference: Methodology of long-term clinical trials in psychiatry. Pharmacopsychiat 27: 101–107
Dardennes R, Even C, Bange F, Heim A (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorder. Br J Psychiatry 166: 378–381
Davis JM (1976) Overview: Maintenance treatment in psychiatry: II. Affective disorders. Am J Psychiatry 133: 1–13
Glen AIM, Johnson AL, Shepherd M (1984) Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med 14: 37–50
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Sauer H, Tegeler J, Wetterling T (1997a) Lithium versus carbamazepine in the maintenance treatment of schizoaffective disorder — a randomised study. Eur Arch Psychiatry Clin Neurosci 247: 42–50
Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Sauer H, Tegeler J, Wetterling T (1997b) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders–a randomised study. J Aff Disord 43: 151–161
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Sauer H, Tegeler J, Wetterling T (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar disorder: a randomised study. J Affect Disord 40: 179–190
Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1993) The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders. J Affect Disord 28: 257–265
Greil W, Schmidt S (1985) Medikamentöse Rezidivverhutung von affektiven Psychosen. In: Hippius H, Greil W (Hrsg.) Psychiatrie fur die Praxis 2. Diagnostik and Therapie depressiver Storungen. MMU, München, pp. 54–71
Haag M, Haag H, Eisenried F, Greil W (1984) RBC-choline: changes by lithium and relation to prophylactic response. Acta Psychiatr Scand 70: 389–399
Keck PEJ, McElroy SL, Strakowski SM, West SA (1994) Pharmacologic treatment of schizoaffective disorder. Psychopharmacol 114: 529–38
Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52 (Suppl 5): 28–34
Kupfer DJ, Rush AJ (1983) Recommendation for depression publications. Psychiat Res 8: 238–240
Lenz G, Wolf R (1986) Prophylaxe der schizoaffektiven Psychosen. In: Müller-Oerlinghausen B, Greil W (Hrsg.) Die Lithiumprophylaxe: Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York, pp. 164–172
Maj M (1984) Effectiveness of lithium prophylaxis in schizoaffective psychoses: application of a polydiagnostic approach. Acta Psychiatr Scand 70: 228–234
Montgomery SA, Dunbar G (1993) Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmaco18: 189–195
Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS (1986) The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3year trial in 83 patients. J Clin Psychiatry 47: 490–494
Prien RF, Klett CJ, Caffey Jr. EM (1973) Lithium carbonate and imipramine in the prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29: 420–425
Schou M (1978) Lithium for affective disorders: cost and benefit. In: Ayd FJ Jr, Taylor IJ (eds) Mood disorders: the world’s major public health problem. Baltimore, Ayd Medical, pp. 117–137
Schou M (1983) (ed) Lithium treatment of manic-depressive illness. A practical guide (2nd revised edition) Basel, Krager
Simhandl C, Denk E, Thau K (1993) The comparative efficacy of carbamazepine low and high serum levels and lithium carbonate in the prophylaxis of affective disorders. J Affect Disord 28: 221–231
Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB (1995) Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 56: 5–13
Spitzer RL, Endicott J, Robins E (1982) Forschungsdiagnose-Kriterien ( RDC) Weinheim: Beltz
Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorder. Pharmacopsychiat 29: 103–107
Wittchen HU, Zaudig M, Schramm E, Mombour W, Klug J, Horn R (1987) Strukturiertes Klinisches Interview fur DSM-III-R (SKID-P/4/87). Weinheim: Beltz
World Health Organisation (1978) Glossary and guide to the classification of mental disorders in accordance with the ninth revision of the international classification of diseases. WHO, Geneva
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Greil, W., Erazo, N. (1997). Die M.A.P.-Studie zur Rezidivprophylaxe affektiver and schizoaffektiver Störungen. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-60819-3_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64570-9
Online ISBN: 978-3-642-60819-3
eBook Packages: Springer Book Archive